Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx) Meeting Abstract
| Authors: | Le, X.; Paz-Ares, L.; Van Meerbeeck, J.; Ramirez, S. V.; Galvez, C. C.; Baz, D. V.; Kim, Y. C.; Kang, J. H.; Stroh, C.; Juraeva, D.; Bruns, R.; Otto, G.; Johne, A.; Paik, P. K. |
| Abstract Title: | Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680302306 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.9121 |
| Notes: | Meeting Abstract: 9121 -- Meeting also held virtually -- Source: Wos |
